|Articles|July 1, 2016
- BioPharm International-07-01-2016
- Volume 29
- Issue 7
BioPharm International, July 2016 Issue (PDF)
Click the title above to open the BioPharm International July 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 9 years ago
Bio/Pharma Funding Challenges Could Hurt CDMOs in 2017over 9 years ago
Design and Qualification of Single-Use Systemsover 9 years ago
Managing Biomanufacturing Capacity Expectationsover 9 years ago
Microbiological Testing: Time is of the Essenceover 9 years ago
Recognizing Biopharma Industry Excellenceover 9 years ago
Modular Bioreactor Simplifies Process Developmentover 9 years ago
FDA and Manufacturers Intensify Concerns about Data IntegrityNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
3
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
4
High-Dose Nusinersen Slows Neurodegeneration in SMA Patients, Study Shows
5
